Carlsmed (CARL) vs Spok (SPOK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Carlsmed (CARL) has outperformed Spok (SPOK) over the past year, gaining 1.7% versus a loss of 30.5%. Carlsmed is the larger company by market cap ($383.6 million vs $231.4 million), about 1.7 times the size. Spok pays a dividend yielding 11.30%, while Carlsmed does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | SPOK |
|---|---|---|
| Share price | $14.05 | $11.06 |
| Market cap | $383.60M | $231.35M |
| 1-day change | -2.29% | +0.09% |
| YTD return | +13.77% | -16.15% |
| 1-year return | +1.66% | -30.48% |
| 5-year return | — | +11.50% |
| P/E ratio (TTM) | — | 19.40 |
| Forward P/E | — | 13.17 |
| EPS (TTM) | $-1.08 | $0.57 |
| Dividend yield | 0.00% | 11.30% |
| Annual dividend | $0.00 | $1.25 |
| 52-week high | $17.23 | $16.45 |
| 52-week low | $8.50 | $9.95 |
| Distance from 52-week high | -18.46% | -32.77% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +36.65% | — |
| Average volume | 125.43K | 150.29K |
| Shares outstanding | 27.30M | 20.92M |
| Employees | 127 | 382 |
| Sector | Health Care | Telecommunications |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CARL has outperformed SPOK by 32.1 percentage points over the past year.
- Spok offers a meaningfully higher dividend yield (11.30% vs 0.00%).
- The two companies sit in different sectors: Carlsmed in Health Care and Spok in Telecommunications.
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Health Care · Medical/Dental Instruments · 127 employees
About Spok
SPOK stock →Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance.
Telecommunications · Telecommunications Equipment · 382 employees
CARL vs SPOK FAQ
Which is bigger, Carlsmed or Spok?
Carlsmed (CARL) is larger, with a market capitalization of $383.60M compared with $231.35M for Spok (SPOK).
Which stock has performed better over the past year, CARL or SPOK?
CARL returned +1.66% over the past 12 months, compared with -30.48% for SPOK (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Carlsmed or Spok?
Spok pays a dividend yielding 11.30%, while Carlsmed does not currently pay a regular dividend.
Are Carlsmed and Spok in the same industry?
No. Carlsmed is in the Health Care sector, while Spok is in Telecommunications.